Methinks vision is to provide universal and timely diagnosis to enable life-saving treatments worldwide. Our first focus is on stroke. https://xitter.cf/t.co/nWQTCN7OJT
Barcelona, Espanya
Joined June 2020
- Tweets195
- Following292
- Followers290
- Likes149
We couldn’t be prouder to revisit this incredible discussion at #LSIEurope25 !
A big thank you again to Stephen Wood, Frank Berger, Signe Haughton and Ángel Alberich-Bayarri.
🎥 Watch the full session here: lifesciencemarketresearch.co…
Methinks retweeted
🔸Pau Rodríguez, CEO de @MethinksAI: “vam crear una solució per reduir el temps de tractament de l’ictus a qualsevol hospital mitjançant l’anàlisi de dades mèdiques bàsiques, sense la necessitat d’utilitzar tècniques més avançades”
#JornadaIAGIPS
🎥 Watch the full conversation here: youtube.com/watch?v=FycVd5K0…
Together, we can make quality stroke care accessible to all.
#StrokeCare #AI #MedTech #HealthTech
🧠 #WorldStrokeDay reminds us that access to stroke care should never depend on geography.
At last week’s #WSC, @marcriboj, Boris Pabón & Santiago Ortega-Gutiérrez (@CerebrovascLab) discussed how AI can help expand access to life-saving care in low and middle income countries.
Methinks retweeted
The @US_FDA has cleared the @MethinksAI CTA #Stroke tool for use in the AI-based, automated detection of large vessel occlusions from CT angiography images.
ow.ly/849w50XjpLT
@American_Stroke @WorldStrokeOrg @EVToday
💙 Last Monday together with @Medtronic, we hosted a day at our Barcelona offices — bringing together leaders in #strokecare, #technology, and industry, alongside our #TeamMethinks, to explore a key question: How can #AI transform every step of the stroke patient journey?
🧠 Incredible week at #WSC2025 in Barcelona!
Highlight: @marcriboj, Boris Pabón & Santiago Ortega-Gutiérrez discussed the DONE SYMPLE trial & how #MethinksAI improves access to top medical imaging in lower- and middle-income countries.
#Stroke #AI #HealthTech @CerebrovascLab
🧠 Day 2 at #WSC2025! Stop by Booth 4 to meet our team & see how we’re advancing AI for stroke assessment.
Yesterday at the @Medtronic symposium, @marcriboj & @CerebrovascLab shared the DONE SYMPLE trial — using Methinks to expand treatment access for late-window stroke patients
🧠 Tomorrow we’ll be at #WorldStrokeCongress2025 — right here in Barcelona!
Find us at Booth #4 to meet our team, discover what we’re building, and chat about the future of AI in stroke care.
📍Floor plan: apps.kenes.com/floorplan/#/c…
Excited to connect with everyone! 💬
🎉 Second FDA clearance of the year! Methinks CTA Stroke is now FDA cleared, alongside NCCT, helping U.S. stroke centers deliver faster, smarter AI-powered assessments.
👉More here: neuronewsinternational.com/m…
Methinks retweeted
.@MethinksAI has announced the signing of a collaboration agreement with @SiemensHealth to bring innovative digital solutions for #stroke management to markets in southern Europe
neuronewsinternational.com/m…
🤿 Last Friday we swapped the office for the sea — and it couldn’t have been better! A day of kayaking and snorkeling turned into the perfect mix of laughs, teamwork, and shared memories.
Sometimes the best way to build stronger teams is simply to enjoy something new together.
What an incredible experience at #LSIEurope25 in London! 🚀Our CEO Pau Rodríguez had the privilege of bringing together an outstanding panel on Scaling Impact through Strategic Partnerships, with leaders from @Microsoft, @Siemens, @Medtronic & @QuibimBiomarker .
#HealthTech
Our CEO, Pau Rodríguez, is shaping the stage at #LSIEurope25!
📅 Panel: Scaling Impact through Strategic Partnerships
🕥 Sept 9 | 10:30am
Honored to join leaders from @Microsoft , @Siemens , @Medtronic & @QuibimBiomarker discussing AI in #healthcare.
#HealthTech #healthcareai
🚀 New U.S. study: Methinks AI software for identifying large vessel occlusion in non-contrast head CT - A pilot retrospective study in American population.
With 75% sensitivity & 83% specificity, and now FDA-cleared, we’re ready to transform stroke care!
journals.sagepub.com/doi/10.…
This study led by Alan Flores, @marcriboj , and Santy Ortega, shows that lower ischemic core volumes, automatically estimated on Non-Contrast CT (NCCT) using our deep learning algorithm, are significantly associated with better 90-day functional outcomes and lower risk of sICH.
🚨 New study in #JNIS - Association of initial core volume on non-contrast CT using a deep learning algorithm with clinical outcomes in acute ischemic stroke: a potential tool for selection and prognosis?
Link here: jnis.bmj.com/content/early/2…
@CerebrovascLab #MethinksAI
🧠 Today's #WorldBrainDay
It reminds us of the vital importance of brain health. #Stroke is a leading cause of disability. Fast, accurate assessment saves lives. We strive to transform stroke care by reducing time to treatment.
#BrainHealthForAllAges #StrokeCare #MethinksAI
